Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 45.69 USD 3.58% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Omnicell Inc?
Write Note

Omnicell Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Omnicell Inc
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Omnicell Inc
NASDAQ:OMCL
Cash from Financing Activities
$12m
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Cash from Financing Activities
-$25m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teladoc Health Inc
NYSE:TDOC
Cash from Financing Activities
$4.5m
CAGR 3-Years
-65%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Inspire Medical Systems Inc
NYSE:INSP
Cash from Financing Activities
$7.6m
CAGR 3-Years
-21%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Cash from Financing Activities
-$276.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Cash from Financing Activities
-$17.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Omnicell Inc
Glance View

Market Cap
2.1B USD
Industry
Health Care

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Mountain View, California and currently employs 3,800 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The firm's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The firm's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The firm's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

OMCL Intrinsic Value
44.14 USD
Overvaluation 3%
Intrinsic Value
Price

See Also

What is Omnicell Inc's Cash from Financing Activities?
Cash from Financing Activities
12m USD

Based on the financial report for Sep 30, 2024, Omnicell Inc's Cash from Financing Activities amounts to 12m USD.

What is Omnicell Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-42%

Over the last year, the Cash from Financing Activities growth was -13%. The average annual Cash from Financing Activities growth rates for Omnicell Inc have been -42% over the past three years .

Back to Top